CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 1 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 24,200 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 24,200 | -2.4% | 0.00% | – |
| Q2 2017 | $4,000 | -94.8% | 24,790 | -47.9% | 0.00% | -100.0% |
| Q1 2017 | $77,000 | -37.4% | 47,599 | -44.1% | 0.00% | -40.0% |
| Q4 2016 | $123,000 | -17.4% | 85,155 | +40.2% | 0.01% | -28.6% |
| Q3 2016 | $149,000 | -18.1% | 60,755 | -5.0% | 0.01% | -30.0% |
| Q2 2016 | $182,000 | -64.1% | 63,955 | -23.7% | 0.01% | -69.7% |
| Q1 2016 | $507,000 | -47.5% | 83,855 | -36.8% | 0.03% | -40.0% |
| Q4 2015 | $966,000 | – | 132,606 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |